ClinicalTrials.gg
RecruitingNCT06678880SALIUpdated Aug 5, 2026

Sleep and Light Intervention (SALI) for Menopausal Mood Dysfunction

An interventional study of Phase Advanced Intervention (PAI) and Phase Delay Intervention (PDI) in Depression, Depression During the Menopausal Transition and Menopausal Depression, sponsored by University of California, San Diego. Recruiting at 1 site in United States. Open to female participants aged 45 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by University of California, San Diego · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
45 Years to 75 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Depression by University of California, San Diego — 6 open to participants now, 10 under way, 1 of them phase 3. Depression · University of California, San Diego.

Planned enrollment
8th of 27
120 · median 73
Started
2025
the only one that year
No phase
21 of 30
2 open now
Registered
26th of 30
by date

Among the 30 studies in Depression by University of California, San Diego, this one is the 8th largest by planned enrollment of the 27 interventional ones that give a count, is the only one that started in 2025, is one of 21 with no phase, and was the 26th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

6 of the 30 studies in Depression by University of California, San Diego are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 45 Years to 75 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Depression by University of California, San Diego, or all of them as a file.
02

Study summary

**Participants must live in San Diego County**

The purpose of this study is to learn more about an experimental Sleep \& Light Intervention (SALI) for menopausal mood changes or depression. Researchers want to find out whether adjusting the body's internal clock-which helps regulate sleep, hormones, mood, and energy- can improve symptoms such as depression, poor sleep, and low energy during menopause.

Read the detailed description

Our bodies naturally follow a 24-hour internal clock that helps regulate sleep, hormones, mood, and energy. During menopause, hormonal changes can disrupt the timing of this internal clock, which may contribute to mood changes, sleep problems, and low energy.

Participants will be asked to change their sleep timing for one night and use bright light at specific times of day for two weeks. In previous studies, some women experienced improvements in mood within days to weeks. SALI does not use medication and has few side effects.

Participants must live in San Diego County. Interested individuals will first complete a screening process to help determine whether this study is a good match for them and whether participation would be appropriate and safe. The screening includes questionnaires and interviews about health, mood, sleep, and mental health history. Not everyone who is screened will qualify to participate.

Study participation is approximately 4 ½ months, and includes:

  • 4 weeks of wearing an activity/light wrist sensor
  • 2 overnight urine collections to measure melatonin, the best measure of human circadian rhythms, and a hormone that helps regulate the timing of sleep
  • 1 night where the timing and duration of your sleep will be adjusted
  • 2 weeks of daily light box usage (30 minutes per day at a specified time) and daily surveys to track mood \& side effects
  • Regularly scheduled Zoom interviews \& online surveys to monitor your mood \& sleep before and after SALI

All study activities can be done from the comfort of your home. Researchers hope this work will lead to new ways to improve mood and sleep during menopause and help identify treatments that can be tailored to each person's biological rhythms.

This is a research study, not a clinical treatment. Participation is confidential and voluntary. Participants may or may not benefit directly from participating. To receive full compensation, participants are required to complete study tasks on scheduled days.

03

Conditions studied

  • Depression
  • Depression During the Menopausal Transition
  • Menopausal Depression

Browse trials for

Keywords

  • Menopause
  • depression
  • sleep and light intervention
  • melatonin
  • circadian rhythm
  • Chronobiology
04

Who can participate

Ages eligible
45 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 45-75 years old
  • Experiencing significant down, sad or hopeless feelings that are affecting their daily life
  • These mood changes started or got worse during the menopause transition
  • Irregular or no menstrual cycle for at least 6 months
  • Non-smoking
  • Located in San Diego County

Exclusion criteria

Exclusion Criteria:

  • Untreated sleep apnea
  • Migraine headaches that are triggered or worsened by bright light
  • Currently suicidal or psychotic
  • History of bipolar disorder
  • A medical condition or job where fatigue or changes in sleep schedule could be unsafe
  • Planning to start, stop, or change medications in the next 4 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Group 1

    Participants assigned to the experimental condition.

    Behavioral: Phase Advanced Intervention (PAI)

  • Active comparator
    Group 2

    Participants assigned to the active comparator condition.

    Behavioral: Phase Delay Intervention (PDI)

Interventions

  • BehavioralPhase Advanced Intervention (PAI)

    Phase-advanced restricted sleep (i.e., sleep 9pm-1am only) for 1 night, followed by morning bright white light for 30 min/day for 2 weeks.

  • BehavioralPhase Delay Intervention (PDI)

    Phase-delayed restricted sleep (i.e., sleep 3am to 7am only) for 1 night, followed by evening bright white light for 30 min/day for 2 weeks.

06

What researchers measure

Primary outcomes

  1. Urinary 6-sulfatoxymelatonin (6-SMT)

    Collected to measure melatonin, a hormone that helps regulate your sleep and body clocks.

    Time frame: Urine is collected at baseline and after completing two-week intervention.

  2. Structured Interview Guide for the Hamilton Rating Depression Scale with Atypical Depression Supplement (SIGH-ADS)

    A clinician-conducted interview that asks about symptoms of depression, including mood, sleep, appetite, energy, and other emotional and physical symptoms.

    Time frame: Completed at baseline and after completing two-week intervention.

  3. Patient Health Questionnaire (PHQ-9)

    A brief questionnaire that asks about common symptoms of depression, such as mood, sleep, energy, appetite, and concentration.

    Time frame: Completed at baseline and after completing two-week intervention.

  4. Sleep Quality Rating (SQR)

    A brief questionnaire to rate how well you have been sleeping and whether you have experienced any sleep-related problems.

    Time frame: Completed at baseline and after completing two-week intervention.

07

Study locations

1 of 1 sites recruiting
  • University of California San Diego Hillcrest Medical Center
    San Diego, California 92103, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — There is not a plan to directly share individual participant data (IPD) with other investigators. If such data is requested, the investigators will consider each request individually to determine whether sharing of IPD is appropriate or feasible. However, the investigators will be providing de-identified data to the National Institution for Mental Health Data Archive (NDA) throughout the duration of the study as required by NIH. This data will be available to other investigators after the conclusion of the study per the guidelines and restrictions established by the NDA.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Dec 2028, 45 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 45 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2024
First posted
Nov 7, 2024
StartActual
Mar 11, 2025
Primary completionEst.
Dec 2028
CompletionEst.
Feb 28, 2029
Last update
Aug 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06678880
Responsible party
Barbara L. Parry, M.D. (Professor of Psychiatry, University of California, San Diego) — Principal investigator
First posted
Nov 7, 2024
Start date
Mar 11, 2025
Primary completion
Dec 2028 (estimated)
Completion
Feb 28, 2029 (estimated)
Last update
Aug 5, 2026

Study contacts

Jennifer A Perrott, MSW
Contact
jperrott@health.ucsd.edu
(407) 619-9441
David Sommerfeld, Ph.D.
Contact
dsommerfeld@health.ucsd.edu
(407) 966-7703 ext. 243609
Barbara Parry, M.D.
principal investigator · University of California, San Diego

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion